NEW YORK (Reuters Health)—Compared with cyclophosphamide, rituximab treatment poses less malignancy risk in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), European researchers report. Dr. Emma E. van Daalen of Leiden University Medical Center in the Netherlands tells Reuters Health, “Previous studies reported an increased malignancy risk in patients with AAV, which has been associated…
U.S. Insurer Lobby Group Seeks Delay in 2018 Obamacare Deadline
NEW YORK (Reuters)—The largest lobbying group for health insurers has asked U.S. lawmakers weighing the fate of Obamacare to push back the due date for 2018 individual insurance submissions to regulators in hopes of obtaining greater clarity on the program’s future later on. Republican leaders including President-elect Donald Trump and U.S. Senate Majority Leader Mitch…
New GAC Chair Picks up the Baton
It’s an honor and a thrill to be the next chair of the Government Affairs Committee. Boy, do we have a big year ahead.
Celecoxib & Cardiovascular Death: NSAID Safety Under Review
A recent study showed that at moderate doses celecoxib may be noninferior with respect to cardiovascular safety compared with ibuprofen or naproxen…
RISE Registry Promises to Improve Care & Research for Rheumatology
In 2014, the ACR launched the Rheumatology Informatics System for Effectiveness (RISE), a national electronic health record (EHR)-enabled registry. The goal: To help participating rheumatologists and practices leverage the new wave of big data created by the use of EHR, advance research and improve overall quality of care. A new analysis examines the RISE structure and the initial patient data collected by the registry…
U.S. Court Puts Obamacare Case On Hold Until Trump Takes Office
WASHINGTON (Reuters)—A federal appeals court on Monday brought to an end President Barack Obama’s bid to overturn a ruling that threatens to gut his signature healthcare law by putting the case on hold until after President-Elect Donald Trump, who aims to repeal Obamacare, takes office. The Obama administration had appealed a judge’s May ruling favoring…
Heparin Fails to Prevent Leg, Lung Clots After Arthroscopy, Casting
NEW YORK (Reuters Health)—Low-molecular-weight heparin failed to prevent symptomatic venous thromboemboli in people receiving knee arthroscopy or a lower leg cast, according to a pair of studies conducted in the Netherlands. The treatment is controversial because there is little clear evidence that heparin wards off clots in such instances. The research team, led by Dr. Raymond…
3 Ways the ACR Helps Practices Thrive
The ACR can be the first line of defense for rheumatologists when it comes to compliance efforts, quality control and oversight of physician billing and coding practices, says ACR Director of Practice Management Antanya Chung, CPC, CPC-I, CRHC, CCP. The ACR is focused on providing the support its members want and need. “We want to…
New Insights into the Structure of Collagen Fibril
A study of knee and hip articular cartilage found that thick fibers were bundles of thin fibrils—like a multi-thread rope in which each thread corresponds to a prototypic sub-fibril. The organization of the fibers also differed between the cartilages of distinct tissues, which may explain how a breakdown in the fiber pattern contributes to pathology…
Verdict: Johnson & Johnson to Pay More Than $1 Billion for Defective Hip Implants
(Reuters)—A federal jury in Dallas on Thursday ordered Johnson & Johnson (J&J) and its DePuy Orthopaedics unit to pay more than $1 billion to six plaintiffs who said they were injured by Pinnacle hip implants. The jurors found that the metal-on-metal Pinnacle hip implants were defectively designed and that the companies failed to warn consumers…
- « Previous Page
- 1
- …
- 463
- 464
- 465
- 466
- 467
- …
- 816
- Next Page »